Andrea N. Riner, M.D., M.P.H., from University of Florida in Gainesville, and colleagues assessed the impact of eligibility criteria on disparities in PDAC clinical trial candidacy. The analysis included 676 patients with PDAC who sought care at Virginia Commonwealth University Health (2010 to 2019). Read more . . .
Traditional eligibility criteria differentially exclude Black patients from participating in clinical trials for pancreatic ductal adenocarcinoma (PDAC), according to a study published online March 22 in the Journal of Clinical Oncology.